Evolus Net Income From Continuing Ops from 2010 to 2026

EOLS Stock  USD 6.65  0.02  0.30%   
Evolus Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss will likely drop to about -47.6 M in 2026. From the period from 2010 to 2026, Evolus Net Loss quarterly data regression had mean square error of 1155.2 T and mean deviation of  22,734,765. View All Fundamentals
 
Net Loss  
First Reported
2015-12-31
Previous Quarter
-17.1 M
Current Value
-15.7 M
Quarterly Volatility
18 M
 
Yuan Drop
 
Covid
Check Evolus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.9 M, Interest Expense of 22.6 M or Selling General Administrative of 228.6 M, as well as many indicators such as Price To Sales Ratio of 4.3, Dividend Yield of 0.0 or PTB Ratio of 117. Evolus financial statements analysis is a perfect complement when working with Evolus Valuation or Volatility modules.
  
Build AI portfolio with Evolus Stock
Check out the analysis of Evolus Correlation against competitors.

Latest Evolus' Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Evolus Inc over the last few years. It is Evolus' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolus' overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Evolus Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(49,263,700)
Coefficient Of Variation(72.22)
Mean Deviation22,734,765
Median(45,378,000)
Standard Deviation35,578,882
Sample Variance1265.9T
Range158.5M
R-Value(0.38)
Mean Square Error1155.2T
R-Squared0.14
Significance0.13
Slope(2,677,937)
Total Sum of Squares20253.7T

Evolus Net Income From Continuing Ops History

2026-47.6 M
2025-45.4 M
2024-50.4 M
2023-61.7 M
2022-74.4 M
2021-46.8 M
2020-163 M

About Evolus Financial Statements

Evolus shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Evolus investors may analyze each financial statement separately, they are all interrelated. The changes in Evolus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Evolus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-45.4 M-47.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.